Table 1.
Study cohort characteristics and MC consumption habits.
| Age (years) | 52.7 (18.1) |
| Gender f/m | 11/12 |
| Age of dystonia onset (years) | 37.4 (22.5) |
| Disease duration (years) | 15.26 (11.5) |
| Mode of consumption (oil/inhalation/both) | 10/11/2 |
| Cannabis duration of use (years) | 2.5 (2.9) |
| Current monthly dose (grams) | 22.3 (20.1) |
| Percent THC in MC product | 10.6 (6.6) |
| Percent CBD in MC product | 8.0 (5.6) |
| Frequency of consumption (times per day) | 3.3 (4.3) |
| Quantity of puffs/drops in each use | 7.0 (5.6) |
| Estimated THC daily dose (mg) | 101.4 (150.7) |
| Estimated CBD daily dose (mg) | 51.4 (41.6) |
| Percentage of dystonia improvement (0%–100%) a | 47.5 (35.4) |
Data are presented as mean (standard deviation). f/m, female/male; mg, milligrams; MC, medical cannabis; THC, tetrahydrocannabinol; CBD, cannabidiol.
a
n = 22, one patient resigned to answer.